ARKK Holdings of 10x Genomics (TXG) - Updated Daily

Shares HeldWeight In Fund

Trades of TXG Made In ARKK

Why do the number of shares of a company held in an ARK ETF go up or down even when no trades are reported?

Maxinomics.com icon

Date	Direction	Shares	Fund Weight	Fund

July 15, 2022	BUY	235.807k	0.0929%	ARKK
February 22, 2022	BUY	177.981k	0.1273%	ARKK
February 17, 2022	BUY	299.962k	0.1912%	ARKK
January 28, 2022	SELL	83.970k	0.064%	ARKK
January 27, 2022	SELL	2.944k	0.0022%	ARKK

1
2
3
4
5
•••
9
5 / page

Key Statistics

Statistics

Institutional Ownership Trends

News That Matters

🕵🏼Found In	🏷Last Price
ARKKARKG	$38.97
⚖️Weighting	🧢Market Cap
1.63%	$4.46b
🏋🏿‍♂️Weight Rank In ARKK	🧮Price to Sales
23	8.86
🏋️‍♀️Weight Rank Across All Funds	🌏Country
24	🇺🇸United States
💳ARK Estimated Cost Average	🎫ARK Ownership Percent
$153.19	3.39%

Description
10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
Website
www.10xgenomics.com

Research Notes and Commentary for TXG

February 22, 2022

February 22, 2022: ARK Trades and Storylines

November 4, 2021

TXG Close to Profitability, PACB Ramping

August 20, 2021

August 18-20, 2021: ARK Trades and Storylines

June 10, 2021

June 7-9, 2021: ARK Trades and Storylines

January 29, 2021

Ark Trades and Storylines

10x is a workflow company that sells their system to the next-generation therapy companies like CRSP, FATE, CLLS and a host of other companies in...

January 7, 2021

Daily Ark Digest